within Pharmacolibrary.Drugs.ATC.P;

model P01CX01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 5e-05,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.286,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 1.64,
    k12             = 6.8,
    k21             = 6.8
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>P01CX01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Pentamidine isethionate is an antimicrobial agent used primarily for the treatment and prevention of Pneumocystis jirovecii pneumonia (PCP), leishmaniasis, and African trypanosomiasis. It is mainly reserved for use in individuals who cannot tolerate first-line treatments. The drug is administered either intramuscularly or intravenously, and is not typically given orally due to poor absorption. Pentamidine is no longer a first-line treatment for PCP due to toxicity concerns but is still used in certain patient populations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adult patients with Pneumocystis jirovecii pneumonia, intravenous administration.</p><h4>References</h4><ol><li><p>Conte, JE (1991). Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis. <i>The Journal of infectious diseases</i> 163(1) 169–175. DOI:<a href=\"https://doi.org/10.1093/infdis/163.1.169\">10.1093/infdis/163.1.169</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1984463/\">https://pubmed.ncbi.nlm.nih.gov/1984463</a></p></li><li><p>Conte, JE, et al., &amp; Golden, JA (1990). Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial. <i>Annals of internal medicine</i> 113(3) 203–209. DOI:<a href=\"https://doi.org/10.7326/0003-4819-113-3-203\">10.7326/0003-4819-113-3-203</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2197911/\">https://pubmed.ncbi.nlm.nih.gov/2197911</a></p></li><li><p>Navin, TR, et al., &amp; Juranek, DD (1987). Effect of azotemia in dogs on the pharmacokinetics of pentamidine. <i>The Journal of infectious diseases</i> 155(5) 1020–1026. DOI:<a href=\"https://doi.org/10.1093/infdis/155.5.1020\">10.1093/infdis/155.5.1020</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3559276/\">https://pubmed.ncbi.nlm.nih.gov/3559276</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end P01CX01;
